INS and metabolic disease: On the other hand, a systematic review carried out by Casillas Santana et al. (2021) [266] hypothesizes that the relationship between these three pathologies is because T2DM is a metabolic disorder characterized by hyperglycemia in the blood, the result of altered secretion or action of insulin.